Colorectal Cancer Clinical Trial
Official title:
Promoting CRC Screening in a Hard-To-Reach, Low-Income Minority Population
The purpose of this study (Healthy Colon Project II) is to evaluate different educational approaches for increasing rates of colorectal cancer (CRC) screening in a hard-to-reach urban minority population with health insurance.
This project is an extension of the investigators' earlier study (Healthy Colon Project I)
in which the investigators demonstrated that telephone outreach to individuals had a
significant effect on CRC screening in a hard-to-reach, working class, urban minority
population (~27.0% screened who received telephone outreach vs. ~6.1% screened who received
printed educational materials). Additional investigation suggested the possible benefits of
intervening with primary care physicians (PCPs) regarding their CRC screening referral and
follow-up practices.
In the current project, the investigators conducted a 3-group randomized trial. The aims are
as follows: Aim 1: Evaluate the incremental effect of tailored telephone education (TTE),
over and above the effect of academic detailing (AD), for increasing rates of CRC screening
12-months post-randomization; Aim 2: Evaluate the effect of academic detailing alone (AD)
over minimal intervention (control group), for increasing rates of CRC screening 12-months
post-randomization; Aim 3: Identify factors that mediate the effectiveness of the
interventions; and Aim 4: Identify factors that moderate the effectiveness of the
interventions among subgroups.
In one group, participants received printed education materials. In a second group,
participants' PCPs received academic detailing (AD) to improve CRC screening referral and
follow-up practices. And in a third group, PCPs received AD and participants received
tailored telephone education (TTE). Participants were members of a union-based,
self-administered and self-insured benefit fund in the NYC metropolitan area.
The educational intervention approaches were informed by the investigators' earlier study
among this population, with the goal of helping participants to make an informed choice
about screening. The CRC PEM described the importance of early detection and prevention,
risk factors, and the importance of talking to the subject's doctor about CRC screening. The
PEM highlighted colonoscopy as being the only test that can identify and prevent CRC and
described how to prepare for a colonoscopy beginning seven days prior to the test. The PEM
also described other CRC screening tests, including the FOBT, FIT, sigmoidoscopy, barium
enema and virtual colonoscopy. Academic detailing (AD) involved an in-person visit from a
member of the research team who attempted to communicate strategies for improving CRC
screening uptake in the practice's patient panel. In cases where the PCP was unavailable, an
office staff member was approached. A brief description of the RCT was followed by a
semi-structured interview assessing usual practice regarding CRC screening referral and
follow up. The direction of the discussion was guided by PCP responses. A variety of
resources were provided: a binder with up-to-date scientific evidence about CRC screening
recommendations and printed patient education materials, and order forms for refilling
supplies. Specific directives were following up to make sure patients had made appointments
with a gastroenterologist and offering 3-day FOBT. The detailer attempted to elicit a verbal
commitment to do at least one new thing to strengthen the probability that patients would be
screened. The TTE was based on the investigators' previously tested model and involved a
semi-structured protocol in which the first goals were to build rapport and assess level of
knowledge and readiness to be screened. In contrast to the earlier RCT, the current study's
TTE clearly represented colonoscopy as the screening method of choice, while encouraging
alternative screening methods as well. This emphasis was consistent with goals of the New
York City Department of Health and Mental Hygiene and the American Cancer Society at the
time of the study. Rapport established, the TTE dialogue focused on identifying and
addressing barriers that might impede receipt of screening. Verbal commitments were
elicited: to speak with the PCP and make an appointment for a colonoscopy, or request a home
stool test, as appropriate. Follow up calls assessed progress towards achieving goals.
Three types of data were collected. Baseline survey data assessed eligibility and measured a
variety of demographic and other variables. Implementation data monitored the extent to
which the AD and TTE interventions had been conducted as planned. And outcome data (CRC
screening one year post-randomization) was based on medical claims data.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |